Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.
What the source covers
The linked WITS data concerns pharmaceutical trade under HS chapter 30. It is not a peptide-only series or a record of BLOPEP sales.
Keep the scope clear
These independent sources do not establish a partnership with BLOPEP, certification of our products or approval of a particular batch. Follow the primary document for details and limitations.
Sources and verification scope
Brazil pharmaceutical imports by partner, HS 30, 2025 ↗
WITS / UN Comtrade
Source details (original language)
- Scope
- Brazilian imports of pharmaceutical products, HS chapter 30
- Document section
- Reporter Brazil, partner China; trade value 1000 USD
- Limitations
- Not peptide-only, not all APIs, and not Bolang sales.
- Claim verification date
- 2026-09-09